Publications by authors named "Susan Minton"

Claim this Profile
G
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.
Matteo Lambertini, Halle C F Moore, Robert C F Leonard, Sibylle Loibl, Pamela Munster, Susan Minton

J Clin Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of indoximod in patients with advanced malignancies.
Hatem H Soliman, Susan E Minton, Hyo Sook Han, Roohi Ismail-Khan, Anthony Neuger

Oncotarget· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors.
Manik Amin, Susan E Minton, Patricia M LoRusso, Smitha S Krishnamurthi, Cheryl A Pickett

Invest New Drugs· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer.
Pedro M Enriquez-Navas, Yoonseok Kam, Tuhin Das, Sabrina Hassan, Ariosto Silva, Susan Minton

Sci Transl Med· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of Iyengar yoga for management of aromatase inhibitor-associated arthralgia in women with breast cancer.
Paul B Jacobsen, Suzie Muchnick, Susan Marcus, Patricia Amheiser, Pamela Reiersen, Susan Minton

Psychooncology· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer.
Angela DeMichele, Douglas Yee, Donald A Berry, Kathy S Albain, Christopher C Benz, Susan E Minton

Clin Cancer Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sweat but no gain: inhibiting proliferation of multidrug resistant cancer cells with "ersatzdroges".
Yoonseok Kam, Tuhin Das, Haibin Tian, Parastou Foroutan, Epifanio Ruiz, Susan Minton

Int J Cancer· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors.
Hatem H Soliman, Erica Jackson, Tony Neuger, E Claire Dees, R Donald Harvey, Susan Minton

Oncotarget· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolutionary strategy for systemic therapy of metastatic breast cancer: balancing response with suppression of resistance.
Yoonseok Kam, Tuhin Das, Susan Minton, Robert A Gatenby

Womens Health (Lond)· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors.
L Rhoda Molife, Li Yan, Joanna Vitfell-Rasmussen, Adriane M Zernhelt, Daniel M Sullivan, Susan Minton

J Hematol Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with breast cancer worry 3 years after completion of adjuvant treatment.
Kristin M Phillips, Heather L McGinty, Brian D Gonzalez, Heather S L Jim, Brent J Small, Susan Minton

Psychooncology· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolutionary approaches to prolong progression-free survival in breast cancer.
Ariosto S Silva, Yoonseok Kam, Zayar P Khin, Susan E Minton, Robert J Gillies

Cancer Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2-positive male breast cancer with thyroid cancer: an institutional report and review of literature.
Pooja Bardhan, Marilyn M Bui, Susan Minton, Loretta Loftus, W Bradford Carter

Ann Clin Lab Sci· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
History of major depressive disorder prospectively predicts worse quality of life in women with breast cancer.
Heather S L Jim, Brent J Small, Susan Minton, Michael Andrykowski, Paul B Jacobsen

Ann Behav Med· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Necdin, a negative growth regulator, is a novel STAT3 target gene down-regulated in human cancer.
Rachel Haviland, Steven Eschrich, Gregory Bloom, Yihong Ma, Susan Minton

PLoS One· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Male breast cancer: management and follow-up recommendations.
John V Kiluk, Marie Catherine Lee, Catherine K Park, Tammi Meade, Susan Minton

Breast J· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.
Pamela N Munster, Amy P Moore, Roohi Ismail-Khan, Charles E Cox, Mensura Lacevic, Susan E Minton

J Clin Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of exercise to quality of life in cancer patients beginning chemotherapy.
Leigh Anne Faul, Heather S Jim, Susan Minton, Mayer Fishman, Tawee Tanvetyanon

J Pain Symptom Manage· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase III, randomized, open-label trial.
Nicholas J Robert, Mansoor N Saleh, Devchand Paul, Daniele Generali, Laurent Gressot, Susan E Minton

Clin Breast Cancer· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I/II trial of valproic acid and epirubicin/FEC.
Pamela Munster, Douglas Marchion, Elona Bicaku, Mira Lacevic, Jongphil Kim, Susan Minton

Clin Cancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of gemcitabine and irinotecan in metastatic breast cancer with correlatives to determine topoisomerase I localization as a predictor of response.
Stacy Moulder, Nickola Valkov, Anthony Neuger, Jimin Choi, Ji Hyun Lee, Susan Minton

Cancer· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study.
Pamela Münster, Douglas Marchion, Elona Bicaku, Morgen Schmitt, Ji Hyun Lee, Susan Minton

J Clin Oncol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First study of the safety, tolerability, and pharmacokinetics of CP-724,714 in patients with advanced malignant solid HER2-expressing tumors.
Pamela N Munster, Carolyn D Britten, Monica Mita, Karen Gelmon, Susan E Minton

Clin Cancer Res· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
Charles E Cox, John M Cox, Laura B White, Nicholas G Stowell, John D Clark, Susan Minton

Ann Surg Oncol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression.
Nills Diaz, Susan Minton, Charles Cox, Tammy Bowman, Tanya Gritsko

Clin Cancer Res· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis